SSEA-5, an antibody defining a novel surface glycan on human pluripotent stem cells and its application to remove teratoma-forming cells as part of a surface antibody panel

A significant risk in the clinical application of human pluripotent stem cells (hPSCs), including human embryonic and induced pluripotent stem cells (hESCs and hiPSCs), is teratoma formation from residual undifferentiated cells. We have raised a monoclonal antibody (mAb) against hESCs, designated SS...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Tang, Chad, Lee, Andrew S., Volkmer, Jens-Peter, Sahoo, Debashis, Nag, Divya, Mosley, Adriane R., Inlay, Matthew A., Ardehali, Reza, Chavez, Shawn L., Pera, Renee Reijo, Behr, Barry, Wu, Joseph C., Weissman, Irving L., Drukker, Micha
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2011
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537836/
https://ncbi.nlm.nih.gov/pubmed/21841799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.1947
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια